Related Experiment Video
Updated: Oct 23, 2025

07:22
Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
Published on: April 11, 2025
412
Propensity-matched Comparison of VATS Left Upper Trisegmentectomy and Lobectomy
Bin Zhou1, Xiaoxiong Xu1, Jie Dai1
1Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
The Annals of Thoracic Surgery
|August 24, 2021
Summary
Video-assisted thoracoscopic left upper trisegmentectomy (LTS) and left upper lobectomy (LUL) offer similar oncologic outcomes for stage I non-small cell lung cancer (NSCLC). Both VATS procedures provide comparable disease-free and overall survival when negative margins are achieved.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Video-assisted thoracoscopic surgery (VATS) is a minimally invasive approach for lung cancer resection.
- Left upper trisegmentectomy (LTS) and left upper lobectomy (LUL) are surgical options for stage I non-small cell lung cancer (NSCLC).
- Comparative oncologic outcomes between VATS LTS and LUL require further investigation.
Purpose of the Study:
- To compare the oncologic outcomes of VATS left upper trisegmentectomy (LTS) versus left upper lobectomy (LUL) in patients with stage I non-small cell lung cancer (NSCLC).
Main Methods:
- Retrospective analysis of 1543 patients undergoing VATS LTS or LUL for stage I NSCLC from 2013-2017.
- Propensity-score matching was used to create 273 comparable pairs of patients.
- Disease-free survival (DFS) and overall survival (OS) were analyzed using Kaplan-Meier and log-rank tests.
Main Results:
- No significant differences in operative duration, blood loss, or complications were observed between LTS and LUL groups.
- LUL resulted in longer postoperative hospital stays, greater tumor margin distance, and more lymph nodes harvested compared to LTS.
- Median DFS and OS were comparable between the LTS and LUL groups, with similar outcomes across subgroups.
Conclusions:
- VATS LTS and LUL demonstrate comparable oncologic outcomes for stage I NSCLC.
- The choice between LTS and LUL can be based on achieving negative margins, irrespective of tumor pathology or radiologic findings.
- Both VATS procedures are effective options for early-stage NSCLC management.

